Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone
No Thumbnail Available
Authors
Krasner, Carolyn N.
Poveda, Andres
Herzog, Thomas J.
Vermorken, Jan B.
Kaye, Stanley B.
Nieto, Antonio
Claret, Pilar L.
Park, Youn C.
Parekh, Trilok
Monk, Bradley J.
Issue Date
2012
Volume
127
Issue
1
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Krasner, Carolyn N.; Poveda, Andres; Herzog, Thomas J.; Vermorken, Jan B.; Kaye, Stanley B.; Nieto, Antonio; Claret, Pilar Lardelli; Park, Youn Choi; Parekh, Trilok; Monk, Bradley J. Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone. Gynecologic oncology. 2012, 127(1):161-167.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
Identifier
ISSN
0090-8258
1095-6859
1095-6859
